Humana
About: Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Employees: 65,680
0
Funds holding %
of 7,296 funds
0
Analysts bullish %
of 7 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
48% more call options, than puts
Call options by funds: $2.39B | Put options by funds: $1.62B
42% more funds holding in top 10
Funds holding in top 10: 12 [Q4 2024] → 17 (+5) [Q1 2025]
36% more first-time investments, than exits
New positions opened: 139 | Existing positions closed: 102
2% more funds holding
Funds holding: 861 [Q4 2024] → 880 (+19) [Q1 2025]
5% more repeat investments, than reductions
Existing positions increased: 318 | Existing positions reduced: 303
1% less capital invested
Capital invested by funds: $29.8B [Q4 2024] → $29.6B (-$160M) [Q1 2025]
3.45% less ownership
Funds ownership: 96.29% [Q4 2024] → 92.83% (-3.45%) [Q1 2025]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$268
14%
upside
Avg. target
$302
28%
upside
High target
$326
39%
upside
7 analyst ratings
3 positive
43%
4 neutral
57%
0 negative
0%
Barclays Andrew Mok | 14%upside $268 | Equal-Weight Maintained | 12 Jun 2025 |
Truist Securities David Macdonald | 30%upside $305 | Hold Maintained | 12 May 2025 |
Cantor Fitzgerald Sarah James | 23%upside $290 | Neutral Reiterated | 1 May 2025 |
Oppenheimer Michael Wiederhorn | 32%upside $310 | Outperform Maintained | 1 May 2025 |
Baird Michael Ha | 28%upside $300 | Neutral Maintained | 15 Apr 2025 |
Financial journalist opinion
Based on 37 articles about HUM published over the past 30 days
Neutral
Business Wire
2 days ago
Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana recognizes 10 inspiring National Senior Games athletes who are redefining what it means to age.
Neutral
Business Wire
2 days ago
athenahealth, Humana, and Your Health Closing Critical Gaps at the Point of Care While Reducing Administrative Burden on Clinicians
BOSTON--(BUSINESS WIRE)--athenahealth, a leading provider of network-enabled software and services for healthcare practices nationwide, in collaboration with key partners Humana (NYSE: HUM) and Your Health, a South Carolina-based primary care practice, have received a 2025 Points of Light Award from KLAS. This recognition is for the case study, “Closing Care Gaps & Reducing the Administrative Burden Through Improved Data Sharing.” This recognition highlights how integrating timely and relev.
Neutral
PRNewsWire
5 days ago
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces the Investigation of Humana Inc. (NASDAQ: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
NEWTOWN, Pa. , June 9, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Humana Inc. ("Humana") (NASDAQ: HUM), resulting from allegations of providing potentially misleading business information to the investing public.
Neutral
PRNewsWire
1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
NEW YORK , June 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Neutral
GlobeNewsWire
1 week ago
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Humana Inc. (NYSE: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
NEWTOWN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Humana Inc. (“Humana”) (NYSE: HUM), resulting from allegations of providing potentially misleading business information to the investing public.
Neutral
GlobeNewsWire
1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Neutral
Accesswire
1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Neutral
Reuters
1 week ago
Humana to back curbs to Medicare Advantage billing practices, WSJ reports
Humana has told congressional staffers that it will support moves that would curtail billing practices worth billions in extra payments to the industry, the Wall Street Journal reported, citing staffers and a document viewed by it.
Neutral
WSJ
1 week ago
Humana, the second-biggest Medicare insurer, has told congressional staffers that it will support moves that would curtail billing practices worth billions in extra payments to the industry
The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.
Neutral
Accesswire
1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
NEW YORK CITY, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Charts implemented using Lightweight Charts™